We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
Sets out COVID-19 testing for hospice patients and staff.
How to write up and share your findings
Organisational definitions of terms concerned with risk and risk-related matters.
Guidance on the submission, processing and assessment of all completed paediatric studies sponsored by Marketing Authorisation Holders (MAHs)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Case study from Advai.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Requirements for an Animal Test Certificate (ATC) to carry out the field trial of a veterinary medicine in animals (clinical trial) in the UK.
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Advises how to identify suitable mitigation and adaptation measures in the planning process to address the impacts of climate change.
How the MHRA processes variations to Marketing Authorisations (MAs)
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).